It remains unclear whether the imbalanced pharmacology or the longer half-life of tirzepatide contributes to its superior efficacy in glucose and weight reduction compared to the more balanced dual agonist, NNC0090-2746
Exogenous and endogenous ghrelin in gastroprotection against stress-induced gastric damage
Due to the fact that GLP-1 acting drugs such as dulaglutide, liraglutide, and semaglutide do not need dosage adjustments for patients with renal impairment, these medications are considered to be the most recommended choices for patients who have chronic kidney disease (Zheng et al
Medicare will begin covering GLP-1 medications for obesity through the Medicare GLP-1 Bridge program starting July 1, 2026, offering eligible beneficiaries access for $50 per month
Because peace of mind matters
Mitochondrial uncoupling proteins The mitochondrial uncoupling proteins (UCP-1, UCP-2 and UCP-3) have been suggested to be involved in the development of obesity by controlling the energy expenditure